S. Maliartchouk

Genuine Monovalent Ligands of TrkA Nerve Growth Factor Receptors Reveal a Novel Pharmacological Mechanism of Action*

K. Gehring, A. Cuello, N. Beglova, 2000, The Journal of Biological Chemistry.

Potent human p140-TrkA agonists derived from an anti-receptor monoclonal antibody

R. Quirion, H. Saragovi, H. Le Jeune, 1996, The Journal of neuroscience : the official journal of the Society for Neuroscience.

A designed peptidomimetic agonistic ligand of TrkA nerve growth factor receptors.

A. Cuello, K. Burgess, H. Saragovi, 2000, Molecular pharmacology.

Optimal Nerve Growth Factor Trophic Signals Mediated by Synergy of TrkA and p75 Receptor-Specific Ligands

H. Saragovi, S. Maliartchouk, Wenhua Zheng, 1997, The Journal of Neuroscience.

A role for transferrin receptor in triggering apoptosis when targeted with gambogic acid.

D. Green, L. Qiu, S. Kasibhatla, 2005, Proceedings of the National Academy of Sciences of the United States of America.

A TrkA-selective, Fast Internalizing Nerve Growth Factor-Antibody Complex Induces Trophic but Not Neuritogenic Signals*

A. Cuello, K. Neet, A. Kamen, 1998, The Journal of Biological Chemistry.

Design and solution structure of functional peptide mimetics of nerve growth factor.

K. Gehring, I. Ekiel, N. Beglova, 2000, Journal of medicinal chemistry.

The discovery and mechanism of action of novel tumor-selective and apoptosis-inducing 3,5-diaryl-1,2,4-oxadiazole series using a chemical genetics approach

L. Qiu, S. Kasibhatla, S. Cai, 2005, Molecular Cancer Therapeutics.